MasTec, Inc. (MTZ)

MasTec's stock has been under heavy pressure, and the price is still falling. The shares closed at $180.84 after a 4.34% drop in the last session, sit 59.03% below their 52-week high of $441.43, and trade just 22.61% above the 52-week low of $147.49. The price is below its 50-day and 200-day moving averages ($205.87 and $300.23), and the 200-day average itself sits well above the 50-day average, which is the pattern of a stock still working off a long decline.

The stock has lost ground over most time frames. It is down 8.71% over one week, 14.96% over one month, 33.67% over three months and 56.97% over six months. The one-year figure is a decline of 10.04%. The October 29, 2026 report was different: EPS of $2.96 matched the estimate exactly and the shares rose 4.63% in the next session. The sharpest single move came after the July 30, 2026 report, when EPS of $2.22 came in just below the $2.23 estimate and the shares fell 18.91% in the first session. No cause has been established for either move.

Over the last seven reports, MasTec beat the EPS estimate five times. Two of those beats were followed by a lower share price in the first session, so a beat has not reliably lifted the stock. Net profit margin is 2.80% and operating margin is 5.64%, while return on equity of 14.53% is above the sector median of 13.8%. Analysts expect revenue to rise 27.8% this fiscal year to $18.3B, so the growth story is shared across the forecasts.

At a trailing P/E of 29.50, the stock trades at a premium to peers. The sector median P/E is 16.5, which puts the stock 78.8% above that figure. The gap reflects how much of the company's profit is thin relative to its revenue, with a net margin of 2.80%. Trailing GAAP earnings per share of $6.13 are the basis for the P/E, while the analysts' estimate for this year is $9.12.

All 21 analysts with a current rating rate the stock buy or strong buy, and none rate it hold or sell. Three months ago 19 of 20 ratings were buy. On November 2, 2026, Roth Capital, TD Cowen, Truist Securities and Cantor Fitzgerald each kept their ratings. Citigroup kept its Buy rating on October 23, 2026, and JP Morgan kept its Overweight rating on October 19, 2026. Insiders sold $13.7M of stock across 12 sales over the last 18 months and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases would.

The base case is that the stock stays volatile and trades within a wide range while it rebuilds a trend. The price has to reclaim the 20-day average and then the 50-day average before the trend picture changes, and the shares would need to rise a long way before they approach the 200-day average. Analysts' estimates point to earnings growth of 39.2% this fiscal year and 34.5% next year, and a median 12-month target of $308.00. Those estimates only help the share price if the company keeps delivering results in line with them. The outlook would weaken if the price closes below the 52-week low of $147.49, or if quarterly EPS misses the estimate again, as it did on July 30, 2026, when the shares fell 18.91% in the first session. A sustained recovery above the 50-day average would be the first sign that the market is starting to price in the analysts' growth figures.

Support sits at the 52-week low of $147.49, the only level below the price. A fall to that level would test the lowest point of the past year, a level the shares have not reached in the past year beyond that single figure. Resistance begins at the 20-day exponential moving average of $185.52, which is the nearest level above the price and the first point a rebound would need to clear. Above it sits the 50-day simple moving average at $205.87, which marks the medium-term trend line the stock has been trading below. The 200-day simple moving average at $300.23 is the long-term line, and the 52-week high of $441.43 is the top of the range.